Cargando…
Intermittent Courses of Corticosteroids Also Present a Risk for Pneumocystis Pneumonia in Non-HIV Patients
Introduction. Pneumocystis pneumonia (PCP) is rising in the non-HIV population and associates with higher morbidity and mortality. The aggressive immunosuppressive regimens, as well as the lack of stablished guidelines for chemoprophylaxis, are likely contributors to this increased incidence. Herein...
Autores principales: | Calero-Bernal, Maria L., Martin-Garrido, Isabel, Donazar-Ezcurra, Mikel, Limper, Andrew H., Carmona, Eva M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046011/ https://www.ncbi.nlm.nih.gov/pubmed/27721666 http://dx.doi.org/10.1155/2016/2464791 |
Ejemplares similares
-
Pneumocystis jirovecii pneumonia following corticosteroid therapy
por: Garça, Magda, et al.
Publicado: (2023) -
Lung Epithelial Cell Line Immune Responses to Pneumocystis
por: Kottom, Theodore J., et al.
Publicado: (2023) -
Pneumocystis jirovecii pneumonia: a proposed novel model of corticosteroid benefit
por: Gharamti, Amal A., et al.
Publicado: (2021) -
Positive Pneumocystis jirovecii Sputum PCR Results with Negative Bronchoscopic PCR Results in Suspected Pneumocystis Pneumonia
por: Pennington, Kelly, et al.
Publicado: (2018) -
Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: A strategy for prevention
por: Sowden, Evin, et al.
Publicado: (2004)